直肠癌诊断CT用于放疗计划:单次自适应可满足约束
本研究纳入15例II/III期直肠癌患者,比较基于诊断CT(dCT)制定计划并在计划CT(pCT)上重算的剂量差异,并模拟在线自适应流程。结果显示dCT计划靶区覆盖充分,但重算后CTV和PTV中位覆盖下降、OAR剂量升高,15例均未满足处方约束;而5例在线自适应流程患者均满足靶区覆盖和OAR约束。
要点
- 基于诊断CT制定直肠癌放疗计划可行,但需至少一次在线自适应。
- dCT计划在pCT重算后CTV和PTV中位覆盖下降,OAR剂量升高。
- 15例dCT计划无一在不经在线自适应时满足处方约束。
核心结论
- 使用dCT制定直肠癌放疗计划可行,但至少需要一次在线自适应治疗。
研究设计与样本
- 纳入15例同时具有dCT和pCT的直肠癌患者,在两种扫描上勾画靶区和OAR,基于dCT轮廓制定计划并在pCT上重算评估剂量差异。
- 另对5例具有HyperSight CBCT扫描的患者进行类似计划流程,并用Ethos系统模拟在线自适应工作流,以dCT及其计划为参考、HyperSight CBCT用于自适应。
主要发现
- 基于dCT的计划显示靶区覆盖充分。
- 在pCT上重算后,CTV和PTV的中位覆盖均下降,OAR剂量升高。
- 15例计划中无一在不经在线自适应放疗时满足处方约束。
- 在线自适应工作流中全部5例患者的治疗计划满足靶区覆盖和OAR约束。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With the ultimate aim of reducing time to start radiotherapy treatment in patients with rectal cancer, this study explores the feasibility of omitting a planning CT scan (pCT), by utilizing the diagnostic CT scan (dCT) for treatment planning, with or without plan adaption using online adaptive radiotherapy. METHODS: Fifteen rectal cancer patients, with both dCT and pCT available, were included. Target volumes and organs at risk (OARs) were delineated on both scans, followed by treatment planning based on the dCT contours. Plans were recalculated on the pCT to assess dosimetric differences for target volumes and OARs. Additionally, five patients with HyperSight CBCT scans underwent a similar planning process. An online adaptive treatment workflow was simulated using the Ethos system, where the dCT and its plan served as the reference, and the HyperSight CBCT was used for adaptation. RESULTS: dCT-based plans showed adequate target volume coverage. However, when recalculated on the pCT, median coverage decreased for both CTV and PTV, and OAR doses increased. None of the 15 plans met prescribed constraints without online adaptive radiotherapy. In contrast, for all five patients in the adaptive workflow, the treatment plans met target volume coverage and OAR constraints. CONCLUSION: Using dCT-based treatment planning is feasible for rectal cancer patients but requires at least one online adaptive session. A prospective trial (MEC 2023-0445) is ongoing in patients with rectal cancer, aiming to reduce time to start treatment, by omitting the pCT and using online adaptive radiotherapy workflow.
引用
- Schuurhuizen CSEW, Milder MTW, Sluijter JH, et al. Clinical feasibility of treatment planning on a diagnostic CT scan without or with single fraction plan adaptation in patients with stage II/III rectal cancer. Radiother Oncol. 2025. PMID: 40090419. doi:10.1016/j.radonc.2025.110840
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。